ストックスクリーナーアプリを入手
3.66
9.25%
0.31
アフターアワーズ：
3.53
-0.13
-3.55%
Biomerica Inc (BMRA) 最新ニュース
Biomerica announces Fortel Ulcer Test approved for sale by UAE Ministry - TipRanks
Biomerica (BMRA) Gains UAE Approval for Fortel Ulcer Test | BMRA Stock News - GuruFocus
United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Detection of H. pylori Infection - The Manila Times
United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Ulcer Test for Detection of H. pylori Infection | BMRA Stock News - GuruFocus
BMRA Stock Might Surge: Biomerica’s New Ulcer Test Now Available Across the UAE - Own Snap
United Arab Emirates Ministry Of Health And Prevention Approves Biomerica'S Fortel® Ulcer Test For Detection Of H. Pylori Infection - marketscreener.com
Biomerica Secures Major UAE Approval for Rapid H. Pylori Test as Middle East Expansion Accelerates - Stock Titan
BMRA stock touches 52-week high of $3.84 amid market fluctuations - Investing.com
Financial Health Report: Biomerica Inc (BMRA)’s Ratios Tell a Tale - DWinneX
BMRA stock touches 52-week high of $3.84 amid market fluctuations By Investing.com - Investing.com South Africa
Biomerica’s kidney disease test gains approval for sale in UAE - Yahoo Finance
Biomerica stock plummets on 1-for-8 reverse stock split - MSN
Biomerica’s kidney disease test approved for UAE market By Investing.com - Investing.com Canada
Walmart to Expand Sales of BiomericaÆS Aware Breast Self Exam; Product Will Now Be Available in over 2400 Walmart Stores - marketscreener.com
Biomerica (BMRA) Gains UAE Approval for Fortel Kidney Disease Te - GuruFocus
BiomericaFortel Kidney Disease Test Approved For Sale In UAE - marketscreener.com
Biomerica’s kidney disease test approved for UAE market - Investing.com Australia
United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Disease Test for Early Detection of Kidney Damage | BMRA Stock News - GuruFocus
United Arab Emirates Ministry of Health and Prevention Approves Biomerica's Fortel® Kidney Disease Test for Early Detection of Kidney Damage - The Manila Times
Revolutionary 10-Minute Test Could Help Detect Hidden Kidney Disease in 80% of At-Risk Patients - Stock Titan
Biomerica Stock Set to Reverse Split on Monday, April 21st (NASDAQ:BMRA) - Defense World
Biomerica announces reverse stock split - Medical Buyer
Biomerica announces reverse stock split to meet Nasdaq requirements - Investing.com Australia
Biomerica announces reverse stock split to meet Nasdaq requirements By Investing.com - Investing.com Canada
Biomerica Stock Slumps After Reverse Stock Split Announcement: Retail’s Disappointed - MSN
Crude Oil Moves Higher; Travelers Earnings Beat Estimates - Benzinga
Biomerica Announced 1-for-8 Reverse Stock Split - Nasdaq
Biomerica Plans Reverse Stock Split to Regain Nasdaq Listing Compliance - MarketScreener
Biomerica Announces 1-for-8 Reverse Stock Split To Regain Nasdaq Compliance - Nasdaq
Nasdaq Down Over 2%; Abbott Laboratories Posts Upbeat Earnings - Benzinga
Biomerica (BMRA) Announces 1-for-8 Reverse Stock Split Effective April 2025 | BMRA Stock News - GuruFocus
Biomerica Announces Reverse Stock Split | BMRA Stock News - GuruFocus
Biomerica Announces Reverse Stock Split Effective April 21 - TipRanks
Biomerica, Inc. Announces 1-for-8 Reverse Stock Split Effective April 21, 2025 - Nasdaq
Biomerica's Strategic 1:8 Reverse Split Aims to Secure Nasdaq Future - Stock Titan
3 High-Value Companies With Triple-Digit Upside Potential - The Globe and Mail
Biomerica Reports Third Quarter Fiscal 2025 Financial Results - ADVFN
Biomerica Reports Third Quarter Fiscal 2025 Financial Results | - GuruFocus
Biomerica (BMRA) Reports Q3 Revenue Increase and Lower Expenses - GuruFocus
Wheat Losses Continuing on Tuesday Morning - The Globe and Mail
Biomerica Turns Corner: 10% Growth, Cost Cuts, and Major Regulatory Wins Boost Q3 Results - Stock Titan
BIOMERICA INC SEC 10-Q Report - TradingView
La Mancha Investment buying more Belo Sun Mining (BSX) - The Globe and Mail
Biomerica (NASDAQ:BMRA) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World
Biomerica (NASDAQ:BMRA) Stock Price Crosses Above 200-Day Moving Average – Should You Sell? - Defense World
Enteric Disease Testing Market Set to Witness Significant - openPR.com
Biomerica, Inc. (NASDAQ:BMRA) Short Interest Down 65.5% in March - Defense World
Biomerica (NASDAQ:BMRA) Share Price Crosses Above 200 Day Moving Average – Here’s What Happened - Defense World
Short Interest in Biomerica, Inc. (NASDAQ:BMRA) Grows By 64.6% - Defense World
Biomerica’s tests for IBD conditions gain CE-marking under EU’s IVDR - Yahoo
Biomerica gains EU certification for IBD food intolerance products By Investing.com - Investing.com South Africa
Biomerica gains EU certification for IBD food intolerance products - Investing.com India
Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests Targeting Crohn's Disease and Ulcerative Colitis - The Manila Times
Biomerica Achieves IVDR Certification in the European Union for Food Intolerance Tests ... - The Bakersfield Californian
Can Biomerica's Newly Certified IBD Tests Transform Crohn's and Colitis Management in Europe? - StockTitan
2.06%
0.20%
大文字化:
|
ボリューム (24 時間):